[Economic value of tiotropium in the treatment of chronic obstructive pulmonary disease].

@article{Schramm2005EconomicVO,
  title={[Economic value of tiotropium in the treatment of chronic obstructive pulmonary disease].},
  author={Wolfgang Schramm and D. Haake and Andreas Brandt},
  journal={Praxis},
  year={2005},
  volume={94 46},
  pages={1803-10}
}
The economic value of tiotropium in patients with moderate to severe COPD was analysed in a cost-effectiveness study for the Swiss public health insurance system. The results show a drop in COPD exacerbations in comparison to Ipratropium, Salmeterol and standard care (without use of anticholinergics and beta-adrenergics). The numbers-needed-to-treat of tiotropium in comparison to the other medications in order to avoid severe exacerbations amounted to 8 patients (ipratropium versus tiotropium… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

Similar Papers

Loading similar papers…